Medtechchronicles
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
Medtechchronicles
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
Featured

Alan Goldblatt and SSEM Mthembu Medical: Connecting Innovation to Bedside Care

Michael Robin
Last updated: July 13, 2026 6:52 am
By
Michael Robin
Share
10 Min Read
Alan Goldblatt, Managing Director of SSEM Mthembu Medical
Medtech Chronicles
SHARE

The modern healthcare landscape relies heavily on an invisible backbone: the supply chain of high-tech medical machinery and daily clinical supplies. Without complex diagnostic tools, neonatal incubators, and specialized surgical consumables, doctors cannot save lives. SSEM Mthembu Medical (PTY) LTD fills this critical gap across Southern Africa.

Contents
Bridging the Technological Divide in Southern AfricaThe Professional Path of Alan GoldblattA Mission Rooted in Patient OutcomesThe Fusion of Technical and Logistics PowerNavigating Scale and National ComplianceSpecialized Divisions and Strategic Tech AlliancesCultivating Clinical and Technical ExpertiseSustaining Regional Healthcare Infrastructure

At the center of this enterprise is Alan Goldblatt, the Managing Director. He steers the company through a challenging, rapidly changing marketplace. A business executive in this field must balance commercial success with an ethical focus on healthcare. This profile explores how Goldblatt and his team built a major distribution network that links global healthcare engineering with localized patient care.

Bridging the Technological Divide in Southern Africa

South Africa and its neighboring countries present a unique set of challenges for healthcare systems. Medical institutions often face deep imbalances. While advanced private hospitals require the latest imaging tech, underfunded public clinics frequently run out of basic clinical supplies.

The core issue is geographic and structural isolation. Global technology firms manufacture sophisticated devices in North America, Europe, and Asia. However, they rarely establish direct support networks in Southern Africa. This leaves regional healthcare providers vulnerable to delayed deliveries, broken equipment without local parts, and an absence of technical training.

Hospitals do not just need to buy machines. They require local infrastructure to commission, service, and teach nurses or clinicians how to operate those tools. When an electro-medical device fails in a critical care unit, it stops being a product and becomes a life-threatening bottleneck. Delivering continuous support across thousands of kilometers is the fundamental challenge of Southern African healthcare logistics.

The Professional Path of Alan Goldblatt

Alan Goldblatt serves as the executive leader driving SSEM Mthembu Medical forward. His professional journey reflects a deep background in strategic leadership, medical sales expertise, and specialized corporate governance. Stepping into the role of Managing Director requires an understanding of how international business models fit into complex local compliance frameworks.

Goldblatt took the helm of a mature business structure. Instead of running a small, nimble startup, his job involves managing a sprawling logistics and clinical support engine. His training focused on operational discipline, regulatory adherence, and building sustainable corporate relationships. These skills are critical in an industry where product registration, import regulations, and tender processes can take years to unfold.

A Mission Rooted in Patient Outcomes

What drives an executive to dedicate their career to medical device distribution? For Goldblatt, the motivation stems from the immediate impact of his work. In other industries, operational failure might mean a delayed software launch or a lost retail shipment. In the medical space, failure means a patient goes without a diagnosis or a neonate lacks proper incubation.

This human element shapes the company’s daily corporate mission. Goldblatt aligns the company’s goals around safety and clinical efficacy. This perspective ensures that corporate decisions prioritize long-term clinical utility over quick, high-margin sales. The company selects international partners based on product reliability and their willingness to provide long-term training and support to local teams.

The Fusion of Technical and Logistics Power

SSEM Mthembu Medical did not appear overnight. It formed through an evolution designed to address systemic industry gaps. The foundation began in 1987 with the birth of Specialised Systems Electro Medical (SSEM). The original company focused on niche areas like electrophysiology and respiratory care markets.

By the year 2000, SSEM expanded its product catalog to include advanced ultrasound imaging and diagnostic consumables. This expansion made it a notable name across Sub-Saharan Africa. However, growing a product list creates logistics challenges. To solve this, SSEM contracted Mthembu Medical (Pty) Ltd to manage its warehouse, logistics, and technical support requirements nationally.

The relationship was highly effective. In May 2006, the two entities officially merged to trade as SSEM Mthembu Medical (Pty) Ltd. This merger combined high-end technical product management with an established logistics engine. The consolidation streamlined shipping, cut operational waste, and created a single point of contact for regional hospitals.

Navigating Scale and National Compliance

Expanding a corporate entity in South Africa requires careful attention to social and legislative changes. One of the biggest milestones for the company under its modern management structure was achieving full compliance with domestic transformation laws.

Today, the company operates in line with the Broad-Based Black Economic Empowerment (B-BBEE) frameworks and the Health Care Charter. A black empowerment entity holds 51% of the company’s shares. This structure allows the business to participate at the highest levels of public healthcare procurement while promoting genuine transformation.

Growth also required geographic decentralization. To support healthcare facilities across South Africa, the company built six fully self-sufficient national branches. These hubs are located in key urban centers:

  • Johannesburg (Corporate Headquarters)
  • Cape Town
  • Durban
  • Gqeberha (formerly Port Elizabeth)
  • East London
  • Bloemfontein

Each branch houses its own sales teams, application experts, and field technicians. This setup allows the company to respond to technical failures within hours, bypassing the delays of central dispatch.

Specialized Divisions and Strategic Tech Alliances

The company’s commercial strength lies in its diverse product portfolio. The business is organized into highly specialized product divisions, each operating under a dedicated Product Manager who acts as an internal expert for that specific field.

The product range spans almost every major medical specialty:

  • Patient Monitoring & Ventilation: Supplying continuous EEG monitoring, pulse oximeters, and high-frequency oscillators for intensive care units.
  • Theatre Equipment: Distributing electric and manual operating tables, anesthesia machines, and patient warming systems.
  • Ultrasound Imaging: Partnering with top-tier global brands, like Samsung, to bring advanced 3D/4D and 5D diagnostic solutions to local clinics.
  • Pathology & Laboratory Tech: Providing cold-chain management tools, such as ultra-low temperature freezers (-40ºC to -86ºC) and laminar flow clean benches.

To further expand its footprint, SSEM Mthembu Medical recently acquired Medihosp (Pty) Ltd. This strategic move integrated an extensive new Medical Furniture Division into its portfolio, allowing the company to supply complete hospital ward and furniture solutions alongside its tech infrastructure across South Africa, eSwatini, Lesotho, and Namibia.

Cultivating Clinical and Technical Expertise

Goldblatt’s management style centers on specialization and empowerment. He operates on the principle that medical sales teams must be as knowledgeable as the clinicians they serve. To achieve this, he relies on a dual-support structure for every product line.

First, the company employs factory-trained installation personnel who ensure devices are configured perfectly upon arrival. Second, they deploy clinical applications specialists. These professionals are often trained medical technicians or nurses who understand how the equipment behaves in real-world scenarios. They stand beside doctors in operating theaters or ICU wards, explaining software configurations and running training sessions for hospital staff.

This focus on internal education creates a collaborative culture. Goldblatt empowers his team of over 200 permanent and contract employees by investing heavily in their skills development. This approach reduces staff turnover and ensures customers interact with seasoned experts year after year.

Sustaining Regional Healthcare Infrastructure

The future of SSEM Mthembu Medical involves extending its footprint deeper into the broader Southern African Development Community (SADC). Healthcare needs across the African continent are expanding rapidly, driven by population growth and an increasing burden of both communicable and lifestyle diseases.

Goldblatt’s long-term outlook focuses on digital integration, advanced diagnostics, and telehealth capabilities. Modern electro-medical devices are increasingly connected to cloud networks, allowing for remote diagnostics and preventative maintenance. By integrating these software solutions into their existing distribution framework, Goldblatt aims to support rural clinics that lack full-time engineering staff.

The company is positioning itself not just as a supplier of physical assets, but as a long-term partner in regional healthcare sustainability. Through solid financial footing, regulatory compliance, and a decentralized service model, the business is well-prepared to support the next generation of African medical professionals.

​

Michael Robin
+ postsBio ⮌
  • Michael Robin
    From MRI Physics to a €12M Series A: The Growth Story of Dr. Andreas Lemke and mediaire
  • Michael Robin
    Dr. Andreea Bodnari: From Google Cloud Executive to CEO of ALIGNMT AI
  • Michael Robin
    Zach Newman’s Answer to Legacy EHR Systems: Enzo Health
  • Michael Robin
    The Future of Medical Scribes: Kai Van Lieshout on Scaling Lyrebird Health
TAGGED:Digital HealthcareHealthtechMedtech
Share This Article
Facebook Copy Link Print
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Samsung Biologics to Acquire PolyPeptide in $1.8 Billion All-Cash Deal

The demand for peptide-based medicines is growing rapidly around the world, and…

David Veino: Leading Neuros Medical’s Bioelectric Revolution in Amputee Care

Imagine surviving the severe physical and emotional trauma of losing a limb,…

Inside Phantom Neuro: How Dr. Connor Glass is Revolutionizing the Muscle-Machine Interface

A Radical Shift in Bionic Evolution For decades, the concept of a…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Cancer Treatment Without Chemo Precision Oncology Explained
Future Of Healthtech

Cancer Treatment Without Chemotherapy? The Rise of Precision Oncology

By
Michael Robin
Lars Grieten, co-founder and CEO FibriCheck
Digital Health

Lars Grieten: Transforming Everyday Smartphones into Clinical Heart Monitors

By
Michael Robin
How Researchers Use Generative AI to Analyze Papers
Digital Health

How Researchers Use Generative AI to Analyze Scientific Papers

By
Michael Robin
Mark Rus, CEO and Director of Delix Therapeutics
Featured

Delix Therapeutics CEO Mark Rus on DLX-001 and the Rise of Neuroplastogens

By
Michael Robin
Twitter Linkedin
Company
  • Newsletter
  • News & Perspective
More Info
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

Made by Adaptica Solutions For THE HEALTH CHRONICLES

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?